Protocols
2 protocol(s) meet the specified criteria
Drug: IBRUTINIB
Protocol No.TitleStatus
NCI9534A phase I trial of ibrutinib plus PD 0332991 (palbociclib) in patients with previously treated mantle cell lymphomaOpen
NCI9922A Phase 2 Study of Ibrutinib (PCI-32765) in Refractory Distant Metastatic Cutaneous Melanoma: Correlation of Biomarkers with Response and Resistance Open